Gil Medical Center
Incheon, 405-760, South Korea
NCT Number: NCT01003847
The investigators hypothesize that fenofibrate and fatty acid may have different metabolic effects in hypertriglyceridemic patients
Looking for future studies?
Notify Me25 year–75 year
All sexes
Interventional
Phase 4
Incheon, 405-760, South Korea
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
fenofibrate 160 mg, fatty acids 2 gm, placeob 8 weeks of treatment
Time frame: 8 weeks of treatment
Time frame: 8 weeks of treatment
Gachon University Gil Medical Center
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01129050
Body Weight, Cardiovascular Diseases
Stanford, California, United States
View Trial DetailsNCT00286234
Dyslipidemias, Glucose Metabolism Disorders
Sioux Falls, South Dakota, United States
View Trial DetailsNCT02868177
Body Weight, Diabetes Mellitus
Lille, France
View Trial DetailsNCT00457938
Diabetes, Diabetes Mellitus
Dallas, Texas, United States
View Trial Details